Regenerative Medicine Foundation director highlights the need for patient advocacy in longevity and calls for treatments to be made available to all – not just the few.
Author: Danny Sullivan – Link to Article
Regenerative medicine is one of the most promising areas of longevity technology development. This broad term generally relates to cell-based therapies, which target human cells to restore healthy function in the human body. Yet, despite billions of dollars being invested in research and thousands of clinical trials undertaken, most cell-based therapies are not yet widely available to patients.
Longevity.Technology: In the United States, the Regenerative Medicine Foundation seeks to address the challenges that are currently preventing regenerative medicine from reaching the patients that could benefit from it. The foundation is led by Bernard “Bernie” Siegel, a recognised policy expert in the field, who works to raise public awareness and educate lawmakers and the public on stem cells and regenerative medicine. We caught up with Siegel, a speaker at next month’s Longevity Summit Dublin, to learn more about his work and how it relates to the progress being made in the longevity field.
